We came across a bullish thesis on Altimmune, Inc. (ALT) on WallStreetBets subreddit page by Old-Pomegranate3634. In this article, we will summarize the bulls’ thesis on ALT. ALT Technologies, Inc. share was trading at $6.10 as of Oct 7th. ALT’s trailing P/E was 1.82 according to Yahoo Finance.
[caption id="attachment_366816" align="aligncenter" width="750"]Altimmune (ALT) is developing a promising drug pemvidutide for the growing obesity market. This GLP-1/glucagon dual receptor agonist will address obesity and metabolic...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.